Drug Discovery and Development Consultants Ltd 11438683 false 2024-06-01 2025-05-31 2025-05-31 The principal activity of the company is Drug discovery and development consultants Digita Accounts Production Advanced 6.30.9574.0 true 11438683 2024-06-01 2025-05-31 11438683 2025-05-31 11438683 core:CurrentFinancialInstruments core:WithinOneYear 2025-05-31 11438683 bus:Micro-entities 2024-06-01 2025-05-31 11438683 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 11438683 bus:FullAccounts 2024-06-01 2025-05-31 11438683 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 11438683 bus:RegisteredOffice 2024-06-01 2025-05-31 11438683 bus:Director2 2024-06-01 2025-05-31 11438683 bus:Director4 2024-06-01 2025-05-31 11438683 bus:Director5 2024-06-01 2025-05-31 11438683 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 11438683 bus:Agent1 2024-06-01 2025-05-31 11438683 countries:AllCountries 2024-06-01 2025-05-31 11438683 2023-06-01 2024-05-31 11438683 2024-05-31 11438683 core:CurrentFinancialInstruments core:WithinOneYear 2024-05-31 iso4217:GBP xbrli:pure

Registration number: 11438683

Drug Discovery and Development Consultants Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 May 2025

 

Drug Discovery and Development Consultants Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

2

 

Drug Discovery and Development Consultants Ltd

Company Information

Directors

Dr Stephen Anthony Burbidge

Dr Martyn Clive Pritchard

Dr Maria Isabel Gonzalez Fernandez

Registered office

Cart House 2
Copley Hill Business Park
Cambridge Road
Babraham
Cambridge
CB22 3GN

Accountants

Tim Phillips & Co. Limited Cart House 2
Copley Hill Business Park
Cambridge Road
Babraham
Cambridge
CB22 3GN

 

Drug Discovery and Development Consultants Ltd

(Registration number: 11438683)
Balance Sheet as at 31 May 2025

2025
£

2024
£

Current assets

129,379

115,950

Creditors: Amounts falling due within one year

(43,525)

(44,603)

Total assets less current liabilities

85,854

71,347

Accruals and deferred income

(1,175)

(1,040)

 

84,679

70,307

Capital and reserves

84,679

70,307

1

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2024 - 3).

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and FRS 105 ‘The Financial Reporting Standard Applicable to the Micro-entities Regime.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Approved and authorised by the Board on 18 June 2025 and signed on its behalf by:
 

.........................................
Dr Maria Isabel Gonzalez Fernandez
Director

For the financial year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.